![](https://startllc.com/wp-content/uploads/2024/04/Fetal-Distress-300x175.png)
Raydiant Oximetry Secures FDA Approval for Lumerah Investigational Device Exemption (IDE) Study
The Food and Drug Administration (FDA) has approved the Investigational Device Exemption (IDE) of the Lumerah™ technology for the early detection of fetal distress during labor and delivery.